Background
Dysosma versipellis
(
D. versipellis
) has been traditionally used as a folk medicine for ages. However, the specific phytochemicals responsible for their correlated anti-inflammatory, anti-proliferative and antiviral activities remain unknown.
Purpose
This study aimed to explore the specific active components in
D. versipellis
responsible for its potential anti-inflammatory, anti-proliferative, and antiviral effects, and further elucidate the corresponding mechanisms of action.
Methods
Bioaffinity ultrafiltration coupled to liquid chromatography–mass spectrometry (UF-LC/MS) was firstly hired to fast screen for the anti-inflammatory, anti-proliferative and antiviral compounds from rhizomes of
D. versipellis
, and then further validation was conducted using in vitro inhibition assays and molecular docking.
Results
A total of 12, 12, 9 and 12 phytochemicals with considerable affinities to Topo I, Topo II, COX-2 and ACE2 were fished out, respectively. The anti-proliferative assay in vitro indicated that podophyllotoxin and quercetin exhibited comparably strong inhibitory rates on A549 and HT-29 cells compared with 5-FU and etoposide. Meanwhile, kaempferol displayed prominent dose-dependent inhibition against COX-2 with IC
50
value at 0.36 ± 0.02 μM lower than indomethacin at 0.73 ± 0.07 μM. Furthermore, quercetin exerted stronger inhibitory effect against ACE2 with IC
50
value at 104.79 ± 8.26 μM comparable to quercetin 3-
O
-glucoside at 135.25 ± 6.54 μM.
Conclusion
We firstly showcased an experimental investigation on the correlations between bioactive phytochemicals of
D. versipellis
and their multiple drug targets reflecting its potential pharmacological activities, and further constructed a multi-target and multi-component network to decipher its empirical traditional applications. It could not only offer a reliable and valuable experimental basis to better comprehend the curative effects of
D. versipellis
but also provide more new insights and strategies for other traditional medicinal plants.